Latest Updates of Companies in the Cell Isolation and Analysis Products Market
| Company | Headquarters | Latest Update |
| Thermo Fisher Scientific Inc. | United States | In April 2026, Thermo Scientific equipment, consumables, and solutions support advancing research at every stage of the cell culture process. |
| Danaher Corporation | United States | In May 2025, Danaher Corporation, a worldwide science and technology innovator, announced the launch of a partnership with AstraZeneca to develop and commercialize new diagnostic tools and tests intended to support clinicians in better determining which patients would most benefit from precision medicine treatments. |
| Becton, Dickinson and Company (BD) | United States | In July 2026, BD Biosciences showcased a significant lineup of tools intended to expand the possibilities of cellular analysis. |
| Miltenyi Biotec | United States | Miltenyi Biotec provides research- and clinical-grade products for sample preparation, cell separation, flow cytometry, and cell culture applications. |
| Merck KGaA | Germany | In October 2026, Merck, a significant science and technology organization, entered into a collaboration with Promega Corporation, a worldwide life science services and solutions leader based in Madison, Wisconsin, in the US, to co-develop new technologies that advance drug screening and discovery. |
Recent Developments in the Cell Isolation and Analysis Products Market
- In June 2025, STEMCELL Technologies commercially launched the STEMprep Tissue Dissociator System, a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes.
- In June 2025, STEMCELL Technologies, Canada’s largest biotechnology organization, announced the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell categorization techniques with applications in cell and gene therapy, drug discovery, and general cell research, especially where cells are fragile.
Supply Chain Analysis
R&D:
- Research and development (R&D) in cell isolation and analysis products focuses on increasing the purity, viability, and number of separated cells while ensuring scalability for medical care applications.
- Key Players:Proximity Therapeutics & Triana Biomedicines
Manufacturing Processes:
- The major manufacturing processes are heavily increasing microfabrication, surface chemistry modification, and aseptic assembly in the regulated environments.
- Key Players:Miltenyi Biotec and Merck KGaA
Patient Services:
- Patient services in the cell isolation and analysis products revolve around supporting the vein-to-vein workflow of modified medicines, specifically autologous cell therapies.
- Key Players:Thermo Fisher Scientific, Danaher Corporation
Market Growth
The global cell isolation and analysis products market size was estimated at USD 18.7 billion in 2025 and is predicted to increase from USD 20.91 billion in 2026 to approximately USD 57.05 billion by 2035, expanding at a CAGR of 11.8% from 2026 to 2035. The cell isolation and analysis products market is growing because of increasing technical innovation, rising demand for targeted medicine, and government support for cell-driven therapies.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking